Saccade Diagnostics company

Saccade Diagnostics brings to market for the first time clinically-validated objective tests to help clinicians with diagnostic evaluation and management of psychiatric disorders in patients with mental health complaints. A spin-out from the University of Aberdeen, Saccade has devised a rapid eye-movement test called SaccScan that can help medical professionals diagnose a range of psychiatric disorders, such as schizophrenia, bipolar disorder and major depression within just 30 minutes. It is non-invasive, affordable and easy to administer, allowing non-specialists to operate it with minimal training. The academic founders, Philip Benson and David St Clair, teamed up with Madhu Nair, who took on the role of commercial champion and CEO.
Technology: NeuroTech
Industry: Health Care
Headquarters: Edinburgh, Edinburgh, City of, United Kingdom
Founded Date: 2014-04-14
Employees Number: 1-10
Investors Number: 2
Total Funding: $188.4K
Last Funding Type: Grant

Visit Website
Register and Claim Ownership